SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Kidney drug developer Unicycive Therapeutics' Q3 net loss widens on launch costs

Kidney drug developer Unicycive Therapeutics' Q3 net loss widens on launch costs Overview US biotech

UNCY

Related stories